Not Signed In -
Obesity |
Overweight |
Clinical Trial: An Eighteen Month Efficacy and Safety Study in Obese Patients
This study is not yet open for patient recruitment.
Verified by Merck August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Obesity and obesity-related medical conditions | Drug: An investigational Drug for Obesity | Phase II |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Obese patients with a body mass index between 30kg/m2 and 43 kg/m2, inclusive (BMI between 27 kg/m2 and 43kg/m2, inclusive for those with obesity-related comorbidities including hypertension, dyslipidemia and sleep apnea).
Exclusion Criteria:
- Patients with serious or unstable current or past medical conditions.
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00131430
Toll Free Number 1-888-577-8839
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_044
Last Updated: August 17, 2005
Record first received: August 16, 2005
ClinicalTrials.gov Identifier: NCT00131430
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-23
Last Updated: August 17, 2005
Record first received: August 16, 2005
ClinicalTrials.gov Identifier: NCT00131430
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-08-23
email this page
print this page
bookmark this page
feedback on this page
